SJA Investment Banking: Fundraising required to support the advancement of scientific development programs is one of the most prominent challenges facing life sciences / medical device company executives. SJA assists emerging growth companies raise financing rounds, achieve "exits" / liquidity via M&A, IPO, and APOs (reverse mergers, SPACS), facilitate outreach, negotiate terms, and close transactions. SJA’s network of investors includes retail (Accredited / Angel / Family Office) and institutional (Venture Capital) investors supporting private and public raises including concurrent financings associate with private-to- public transactions. SJA Consulting: Provide strategic advisory services to healthcare companies including Business Development - identify, structure, and negotiate licensing / partnership agreements with major bio pharmaceutical companies SJA Investment Banking: (i) Private Placements - Series A> (ii) Alternative Public Offerings - SPACs, Reverse Mergers (iii) Non-dilutive capital including NIH / SBIR and State-sponsored programs, CPRIT - Cancer Prevention Research Institute of Texas (iv) Mergers and Acquisitions (M&A) Securities offered through Finalis Securities LLC Member FINRA/SIPC. S. Jordan Associates and Finalis Securities LLC are separate, unaffiliated entities